Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

Journal of Cancer Research and Clinical Oncology

Volumn 118, Issue 1, 1992, Pages 35-43

  Bernhardt, Günther ^a   Reile, Herta ^a   Birnböck, Herbert ^a   Spruß, Thilo ^a   Schönenberger, Helmut ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anticancer drug effects; Crystal violet chemosensitivity assays; Human breast cancer cell lines; Microtitration plates; Proliferation kinetics

Indexed keywords

CISPLATIN; CRYSTAL VIOLET; DIETHYLSTILBESTROL DIPROPIONATE; DOXORUBICIN; FLUOROURACIL; MELPHALAN; TAMOXIFEN; UNCLASSIFIED DRUG; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; BREAST CANCER; CELL KINETICS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIVISION; CISPLATIN; DIETHYLSTILBESTROL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLUOROURACIL; GENTIAN VIOLET; HUMAN; KINETICS; MELPHALAN; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0026543285     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/BF01192309     Document Type: Article

References (38)

1. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
2. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors
3. Breast tumor cell lines from pleural effusions
4. Carcinoma of the breast
5. Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of chemosensitivity testing
6. Establishment and characterization of three new continous cell lines derived from human breast carcinomas
7. The use of human cancer cell lines as a primary screening system for antineoplastic compounds
8. HPLC micromethod for simultaneous measurement of estradiol, progesterone, androgen and glucocorticoid receptor levels. Application to breast cancer biopsies
9. Assay of anti-cancer drugs in tissue culture; conditions affecting their ability to incorporate3H-leucine after drug treatment
10. Determination of cell number in monolayer cultures
11. Historical development and current strategy of the National Cancer Institute drug development program
12. The seed stock concept and quality control for cell lines
13. Establishment and characterization of a cell line of human breast carcinoma origin
14. Quantification of cells cultured on 96-well plates
15. d,l-[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer
16. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm
17. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in-vitro
18. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells
19. Computerized determination of growth kinetic curves and doubling times from cells in microculture
20. Comparison of in vitro methods to determine drug-induced cell lethality
21. Comparison of in vitro anticancer-drug screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
22. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
23. Application of a human tumor colony-forming assay to new drug screening
24. On the normality of growth dynamics of neoplasms in vivo: a data base analysis
25. Nonexponential growth by mammalian cells in culture
26. Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity
27. New colorimetric cytotoxicity assay for anticancer-drug screening
28. Measurement of protein using bicinchoninic acid
29. A human cell line from a pleural effusion derived from a breast carcinoma
30. Preclinical drug development: rationale and methods
31. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary
32. Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines
33. Cytotoxicity and viability assays
34. The chromosomal basis of human neoplasia